Loading…

Initial Experience with SPECT Imaging of the Brain Using I-123 p-Iodoamphetamine in Focal Epilepsy

Nineteen patients with complex partial seizures refractory to medical treatment were examined with routine electroencephalograpy (EEG), video EEG monitoring, computed tomography or magnetic resonance imaging, neuropsychological tests and interictal single photon emission computed tomography (SPECT)...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 1989-06, Vol.14 (6), p.428-430
Main Authors: LaMANNA, MARGARET M, SUSSMAN, NEIL M, HARNER, RICHARD N, KAPLAN, LINDA R, HERSHEY, BEVERLY L, BERNSTEIN, DEBORAH R, GOLDSTEIN, PERRY, PARKER, JANET A, WOLODZKO, JOHN G, POPKY, GEORGE L
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nineteen patients with complex partial seizures refractory to medical treatment were examined with routine electroencephalograpy (EEG), video EEG monitoring, computed tomography or magnetic resonance imaging, neuropsychological tests and interictal single photon emission computed tomography (SPECT) with 1-123 iodoamphetamine (INT). In 18 patients, SPECT identified areas of focal reduction in tracer uptake that correlated with the epileptogenic focus identified on the EEG. In addition, SPECT disclosed other areas of neurologic dysfunction as elicited on neuropsychological tests. Thus, IMP SPECT is a useful tool for localizing epileptogenic foci and their associated dynamic deficits.
ISSN:0363-9762
1536-0229
DOI:10.1097/00003072-198906000-00006